BOSTON--(BUSINESS WIRE)--Gelesis (NYSE: GLS), the maker of Plenity for weight management, presented new preclinical data showing weight loss and additional metabolic benefits in mice receiving a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback